We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 357

Federal Circuit says Commission must toe the line in Invisalign ITC case

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 23 2014

In Align Technology, Inc. v. International Trade Commission, the Federal Circuit held that ITC action that violated ITC's own regulations warranted

New guidance from the Federal Circuit on motions to stay litigation pending a PTAB proceeding

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 21 2014

In VirtualAgility Inc. v. Salesforce.com, Inc., No. 2014-1232 (July 10, 2014), the Federal Circuit issued its first opinion directed to the issue of

More changes in Delaware: Judge Stark revises patent case procedures

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 16 2014

Chief Judge Leonard P. Stark of the District of Delaware recently issued revised procedures for managing patent cases that are assigned to him. These

Why are method of treatment claims and method of manufacture claims subject to scrutiny under the USPTO patent subject matter eligibility guidance?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 15 2014

The USPTO has asked for written comments on its patent subject matter eligibility guidance by July 31, 2014. In this article, I discuss why

Federal Circuit holds that even functional claims require structural fence posts

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 11 2014

In AbbVie Deutschland Gmbh v. Janssen Biotech, Inc., the Federal Circuit affirmed the district court decision that found AbbVie's patents directed to

After the Supreme Court's Limelight decision, attention may shift to contract analysis in patent cases

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 2 2014

In Limelight Networks, Inc. v. Akamai Tech., Inc., the Supreme Court unanimously held that there can be no liability for induced infringement of a

Federal Circuit looks for a different kind of unexpected results in BMS v. Teva

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 2 2014

In Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc., the Federal Circuit affirmed the district court’s finding that BMS’s Baraclude patent

USPTO asks for patent subject matter eligibility comments by July 31, 2014

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 30 2014

In a June 30, 2014 Federal Register Notice, the USPTO requested public comments by July 31, 2014 on patent subject matter eligibility under the

District Court upholds FTC Hart-Scott-Rodino rules for pharmaceutical patent transfers

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 26 2014

A federal court has upheld the validity of the FTC's recent rules for reporting certain transfers of exclusive patent rights in the pharmaceutical

How the Supreme Court decision in Alice Corp. v. CLS Bank undermines the USPTO subject matter eligibility guidance

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 24 2014

On June 19, 2014, the Supreme Court issued its decision in Alice Corp. v. CLS Bank International, finding that patents directed to "a